scholarly article | Q13442814 |
P50 | author | Charles Grose | Q57329554 |
Ann Arvin | Q4766238 | ||
P2093 | author name string | Jay Lee | |
Marvin Sommer | |||
Chengjun Mo | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 176-186 | |
P577 | publication date | 2002-12-01 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells | |
P478 | volume | 304 |
Q40234780 | A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus |
Q35956960 | Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. |
Q45359726 | Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice |
Q36099097 | Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication |
Q34004072 | Cholesterol dependence of varicella-zoster virion entry into target cells |
Q34434777 | Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus |
Q36491044 | Conserved herpesvirus protein kinases |
Q37033241 | Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry |
Q43161154 | Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts |
Q37596465 | Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells |
Q90714289 | Duck plague virus gE serves essential functions during the virion final envelopment through influence capsids budding into the cytoplasmic vesicles |
Q35101360 | Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection |
Q37596576 | Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo |
Q33591823 | Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection |
Q40041720 | Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. |
Q37252780 | Genome-wide analysis of T cell responses during acute and latent simian varicella virus infections in rhesus macaques |
Q39753125 | Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells |
Q39320331 | Initial Contact: The First Steps in Herpesvirus Entry. |
Q24307918 | Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread |
Q37932527 | Molecular studies of the Oka varicella vaccine |
Q35076854 | Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells |
Q34977329 | Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo |
Q33640129 | Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses |
Q33724286 | Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo |
Q45370931 | Sequence analysis of the glycoprotein E gene of varicella-zoster virus strains of clades 1, 3 and 5 |
Q35947774 | The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor |
Q33987514 | The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors |
Q27330259 | The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface |
Q35543796 | The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. |
Q33554456 | The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection |
Q60938762 | Varicella Virus-Host Interactions During Latency and Reactivation: Lessons From Simian Varicella Virus |
Q39998958 | Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors. |
Q39214502 | Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis |
Q33833934 | Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model |
Q36424473 | Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread |
Q36987139 | Varicella-zoster virus infection of human neural cells in vivo. |
Search more.